Detailed answers about UK MEDICAL EDUCATION & RESEARCH LIMITED, including incorporation, status, business activity, and accounts information.
When was UK MEDICAL EDUCATION & RESEARCH LIMITED founded?
UK MEDICAL EDUCATION & RESEARCH LIMITED was officially incorporated on 12 May 2025 and is registered under company number 16445785. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is UK MEDICAL EDUCATION & RESEARCH LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of UK MEDICAL EDUCATION & RESEARCH LIMITED?
UK MEDICAL EDUCATION & RESEARCH LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does UK MEDICAL EDUCATION & RESEARCH LIMITED do?
UK MEDICAL EDUCATION & RESEARCH LIMITED operates in the following sectors: 84120 - Regulation of health care, education, cultural and other social services, not incl. social security, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is UK MEDICAL EDUCATION & RESEARCH LIMITED's registered address?
The registered office address of UK MEDICAL EDUCATION & RESEARCH LIMITED is 40 CROSSHILL LANE, LOUGHBOROUGH, UNITED KINGDOM, LE11 2RF. This is the official address filed with Companies House for legal and statutory correspondence.
Is UK MEDICAL EDUCATION & RESEARCH LIMITED financially stable?
Financial accounts for UK MEDICAL EDUCATION & RESEARCH LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.